Assessing the utility of circulating cell-free microRNA as biomarkers for response in a variety of Non Hodgkin Lymphomas

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/1093129

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Non Hodgkin Lymphomas are the most common blood cancer to affect adult Australians. The current strategies for diagnosis, treatment and monitoring of these patients are generic and not tailored to features of particular patientÍs lymphoma or treatment response. We aim to develop a new blood based marker for Lymphoma that can be used to diagnose and monitor NHL patients, to allow treatment to be adjusted according the patients current response to therapy, as indicated by the blood based marker. T

Funded Activity Details

Start Date: 01-01-2015

End Date: 01-01-2017

Funding Scheme: Postgraduate Scholarships

Funding Amount: $92,159.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Haematological Tumours

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

biomarkers | cancer | microrna | non-Hodgkin lymphoma | sequencing

Related Links